| 2008 |
TOPIC |
Dr Jackson Marakalala
(PhD) |
Inhibition of a mycothiol biosynthetic enzyme and a detoxification enzyme as antitubercular drug targets |
Naadia van der Bergh
(MSc) |
Expression and Purification of HGXPRT from plasmodium falciparum and characterization of its interaction with a effector chalcone |
| |
|
| 2009 |
TOPIC |
Dr Erika Jones
(PhD) |
The R563Q Mutation of the Epithelial Sodium Channel Beta Subunit is Associated with Hypertension |
| |
|
| 2010 |
TOPIC |
Wan Iryani Wan Ismail
(PhD) |
The Molecular Basis for Insulin Resistance and Lipodystrophy Induced by Antiretroviral Drugs |
Vuyo Mavumengwana
(PhD) |
Mycothioldisulfide reductase as a drug target |
Dr David Haarburger
(MMed) |
Serum Proteome Changes Following HIV Infection |
Dr Fierdoz Omar
(MMed) |
Investigation of High Molecular Weight Adiponectin in HIV-infected Patients on Antiretroviral Therapy |
Dr George van der Watt
(MMed) |
Whole Blood Mitochondrial DNA Depletion in Human Immunodeficiency Virus-Infected Children |
Dr Carel Haumann
(MMed) |
Investigation of an Atypical Protoporphyric Family in South Africa |
| |
|
| 2011 |
TOPIC |
Dr Ian Ross
(PhD) |
Addisons Disease in South Africa |
Dr Ryan Benjamin
(MMed) |
Establishing and Validating an External Quality Assurance Program for Urine Bicarbonate |
Dr John Stanfliet
(MMed) |
Serum Prolidase Activity as a Marker for Liver Fibrosis in Suspected Liver Disease |
Raymond Moholisa
(MSc) |
Analysis of a Variant in XPNPEP2 in Black African and Coloured South Africans Presenting with Angioedema Induced by Angiotensin I-converting Enzyme Inhibitors |
